Results 21 to 30 of about 763,557 (307)

Biomarkers in Neuroendocrine Tumors

JOP : Journal of the pancreas, 2013
Neuroendocrine tumors are a heterogeneous group of tumors with cells of neuroendocrine differentiation that arise from diverse anatomic sites with varying morphologic and clinical features. Since the natural history and prognosis varies widely between individual neuroendocrine tumor types, there is a critical need to identify accurate prognostic and ...
Marvin, Duque, Irvin M, Modlin, Anumeha, Gupta, Muhammad Wasif, Saif   +3 more
openaire   +2 more sources

Identifying the Risk Factors for Malignant Mammary Tumors in Dogs: A Retrospective Study

Veterinary Sciences, 2023
Mammary cancer is one of the main causes of death in female dogs worldwide, considering that many risk factors are involved in its development. This study aimed to elucidate the relationship between epidemiological and clinical risk factors with the ...
Elis Maressa Gonçalves da Silva, Thaisa Reis dos Santos, Marcelo José Barbosa Silva   +2 more
doaj   +1 more source

Hepatocellular carcinoma: Review of disease and tumor biomarkers. [PDF]

, 2016
© The Author(s) 2016.Hepatocellular carcinoma (HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative
Cox, IJ, Crossey, MM, Fye, HK, Gomez-Romero, M, Holmes, E, Kim, JU, Njie, R, Shariff, MI, Taylor-Robinson, SD   +8 more
core   +1 more source

Serum biomarkers and clinical characteristics of patients with Hodgkin lymphoma [PDF]

Vojnosanitetski Pregled, 2018
Background/Aim. In classical Hodgkin’s lymphoma (cHL) the existing prognostic scoring systems do not include markers that adequately reflect the interaction of malignant Hodgkin and Reed-Sternberg (HRS) cells and tumor environment.
Simonović Olivera, Todorović Milena, Mihaljević Biljana, Stoimenov-Jevtović Tatjana, Petković Ivan, Mačukanović-Golubović Lana, Marjanović Goran   +6 more
doaj   +1 more source

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives [PDF]

, 2019
Oral cancer is the sixth most common cancer type in the world, and 90% of it is represented by oral squamous cell carcinoma (OSCC). Despite progress in preventive and therapeutic strategies, delay in OSCC diagnosis remains one of the major causes of high
Campisi, Giuseppina, Cristaldi, Marta, Di Fede, Olga, Giuliana, Giovanna, Mauceri, Rodolfo, Panzarella, Vera   +5 more
core   +1 more source

Renal Tumors [PDF]

American Journal of Surgical Pathology, 2013
The International Society of Urological Pathology convened a consensus conference on renal cancer, preceded by an online survey, to address issues relating to the diagnosis and reporting of renal neoplasia. In this report, the role of biomarkers in the diagnosis and assessment of prognosis of renal tumors is addressed. In particular we focused upon the
Tan, Puay Hoon, Cheng, Liang, Rioux-Leclercq, Nathalie, Merino, Maria J., Netto, George, Reuter, Victor E., Shen, Steven S., Grignon, David J., Montironi, Rodolfo, Egevad, Lars, Srigley, John R., Delahunt, Brett, Moch, Holger, Panel, Isup Renal Tumor   +13 more
openaire   +4 more sources

The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one [PDF]

, 2018
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice.
Botticelli, A., Marchetti, P., Nuti, M., Rughetti, A., Zizzari, I. G.   +4 more
core   +1 more source

Biomarkers in neuroendocrine tumors

Frontiers in Bioscience, 2010
Here, we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuro endocrine differentiation (defined as "pan ...
BERRETTA M, CAPPELLANI, Alessandro, DI VITA, Maria Domenica, BERRETTA S, NASTI G, BEARZ A, TIRELLI U, CANZONIERI V.   +7 more
openaire   +5 more sources

Circulating Tumors Cells as Biomarkers [PDF]

The Cancer Journal, 2011
Personalized cancer medicine requires the development of tumor-specific biomarkers to optimize selection of targeted therapies and to better assess response to therapy. Current efforts in several tumor types have shown that patients in whom circulating tumor cells (CTCs) are detected have an inferior prognosis relative to those in whom CTCs are not ...
Daniel C, Danila, Klaus, Pantel, Martin, Fleisher, Howard I, Scher   +3 more
openaire   +2 more sources

Special Issue: Molecular Biomarkers in Solid Tumors [PDF]

Genes, 2021
Diagnostic strategies using a next-generation systematic approach have the potential to radically improve the outcome and subsequent quality of life of patients with cancer [...]
Nicola Fusco, Caterina Marchiò, Michele Ghidini, Cristian Scatena   +3 more
openaire   +4 more sources